CD14 and COVID-19: This is associated with the migration of CD14+CD16+ inflammatory transitional and CD14 dim CD16+ non-classical monocytes from the blood to lungs in patients with severe COVID-19 without showing a significant correlation between total CD16+ monocytes, both non-classical and inflammatory cells, and disease severity.